supported by the Major Science and Technology Special Projects of Yunnan Province,China (202002AA100009);the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2021-JKCS-012);the Special Biomedicine Projects of Yunnan Province (202102AA310035);National Natural Science Foundation of China (82104130);Fundamental Research Funds for the Central Universities (3332021072);the Basic Research Projects of Yunnan Province (202101AU070176, 202101AT070286);the Funds for the Training of High-level Health Technical Personnel in Yunnan Province(grant number H-2019063);the Funds for High-level Scientific and Technological Talents Selection Special Project of Yunnan Province(202205AC160015)
Latent varicella-zoster virus(VZV)may be reactivated to cause herpes zoster,which affects one in three people during their lifetime.The currently available subunit vaccine Shingrix^(TM) is superior to the attenuated v...
financially supported by the CAMS Initiative for Innovative Medicine(Grant Number 2017-I2M3-022);Central basic scientific research in colleges and universities(Grant Number 3332019162);the National Natural Science Foundation of China(Grant Number 81503117);the Foundation for Studying Abroad from the China Scholarship Council(Grant Number 201808110121)
The subunit herpes zoster vaccine Shingrix is superior to attenuated vaccine Zostavax in both safety and efficacy,yet its unlyophilizable liposome delivery system and the limited supply of naturally sourced immunologi...